The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients
MN Park - International Journal of Molecular Sciences, 2023 - mdpi.com
Acute myeloid leukemia (AML) is the most common and incurable leukemia subtype.
Despite extensive research into the disease's intricate molecular mechanisms, effective …
Despite extensive research into the disease's intricate molecular mechanisms, effective …
Inferior Overall Survival After Haploidentical Donor Lymphocyte Infusions in Relapsed Myeloid Neoplasms
TM Benoit, A Bachofner… - European Journal of …, 2024 - Wiley Online Library
Objectives Allogeneic hematopoietic stem cell transplantation (HSCT) effectively treats high‐
risk myeloid neoplasms, but relapses post‐HSCT, particularly in acute myeloid leukemia …
risk myeloid neoplasms, but relapses post‐HSCT, particularly in acute myeloid leukemia …
Advancements in Myeloid Leukemia Treatment: A Comprehensive Update
This comprehensive update explores the recent advancements in the treatment landscape
of myeloid leukemia. Myeloid leukemia, a heterogeneous group of hematological …
of myeloid leukemia. Myeloid leukemia, a heterogeneous group of hematological …
The Therapeutic Potential of Herbal Remedies To Prevent Leuke-Mia Stem Cell Reprogramming in Acute Myeloid Leukemia
MN Park - 2023 - preprints.org
Acute myeloid leukemia (AML) is the most common and incurable leukemia subtype.
Despite extensive research into the disease's intricate molecular mechanisms, AML have …
Despite extensive research into the disease's intricate molecular mechanisms, AML have …